IZNN yields 20000000.00% · JNJ yields 2.13%● Live data
📍 IZNN pulled ahead of the other in Year 1
Combined, IZNN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IZNN + JNJ for your $10,000?
IZON Network, Inc., a golf-centric technology and information-dissemination company, creates a golf technology platform in Canada and the United States. The company connects golfers to advertisers by installing multifunctional Web-enabled interactive tablets in golf cars that operate on and are owned by golf courses across the United States. Its Internet-connected interactive tablets provides a host of services to golfers and golf courses, such as GPS-based hole/course information, aerial views of fairways and green, accurate yardage information to hazards and greens, messaging, online scoring, and beverage cart ordering. The company also offers a portfolio of course management tools designed to enable course managers to improve player pace of play through GPS-based cart tracking and communications, increased merchandise, and concession sales through real-time on-tablet promotions, as well as access to additional revenue streams, such as sale of local advertising. In addition, it provides online marketing services. The company was formerly known as Digital Caddies, Inc. and changed its name to IZON Network, Inc. in September 2017. IZON Network, Inc. was incorporated in 2011 and is headquartered in Scottsdale, Arizona.
Full IZNN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.